- Medix Biochemica收購(gòu)了美國(guó)Biostride業(yè)務(wù)，Biostride是藥物濫用、激素類(lèi)檢測(cè)用原料的領(lǐng)先生產(chǎn)商，有著為全球體外診斷市場(chǎng)服務(wù)的悠久歷史
Medix Biochemica has acquired the business of US-based Biostride Inc, a pioneering manufacturer of Drugs of Abuse and Hormone Testing bioreagents with a long history of serving the In-Vitro Diagnostic (IVD) industry worldwide
- 通過(guò)此次并購(gòu)，Biostride將得以通過(guò)Medix的全球網(wǎng)絡(luò)和北美、歐洲、中國(guó)的本地團(tuán)隊(duì)向全球客戶提供其藥物濫用、激素類(lèi)等領(lǐng)域的出色產(chǎn)品
As a result of the acquisition, Biostride's leading portfolio of Drugs of Abuse antibodies and antigens will be available to the global IVD and drug testing customer base through Medix's comprehensive global sales network, with local presence in North America, Europe and China
- 此次并購(gòu)還會(huì)將Biostride的產(chǎn)品納入Medix Biochemica經(jīng)ISO13485認(rèn)證的生產(chǎn)標(biāo)準(zhǔn)中
The acquisition will also bring Biostride's products under Medix Biochemica's ISO13485 certified manufacturing standard
- 本次并購(gòu)與Medix通過(guò)供應(yīng)鏈整合、成為IVD行業(yè)首選的關(guān)鍵原料供應(yīng)商的長(zhǎng)期戰(zhàn)略一致
The acquisition is in line with Medix’s strategy to consolidate the IVD supply chain and become the #1 supplier of critical raw materials to the IVD industry
- Biostride的共同創(chuàng)始人Laura Colin以及總裁Todd Corneillie將在隨后的整合中繼續(xù)擔(dān)任Medix Biochemica的顧問(wèn)
Biostride's co-founder Laura Colin and President Todd Corneillie will continue as advisors to Medix Biochemica following the transaction
通過(guò)收購(gòu)Biostride業(yè)務(wù)，Medix Biochemica將其IVD產(chǎn)業(yè)關(guān)鍵原料產(chǎn)品線擴(kuò)充到藥物濫用相關(guān)抗體、抗原領(lǐng)域。并購(gòu)后，Biostride業(yè)務(wù)將并入Medix Biochemica免疫診斷原料業(yè)務(wù)部。Biostride的共同創(chuàng)始人Laura Colin以及總裁Todd Corneillie將在隨后的整合中繼續(xù)擔(dān)任Medix Biochemica的顧問(wèn)。
Medix Biochemica has acquired the business of Biostride to expand its portfolio of key raw materials for the in vitro diagnostics (“IVD”) industry into Drugs of Abuse antibodies and antigens. As a result of the transaction, the operations of Biostride will be merged with Medix Biochemica's Immunodiagnostic Reagents Business Unit, and Biostride's co-founder Laura Colin and President Todd Corneillie will continue as advisors to Medix Biochemica.
Biostride由Laura Colin和Henry Tom創(chuàng)建于1990年，是全球IVD產(chǎn)業(yè)的抗體、抗原、及酶標(biāo)記抗體、抗原的研發(fā)及生產(chǎn)商，以其藥物濫用及激素檢測(cè)相關(guān)原料而知名。Biostride總部位于美國(guó)加利福尼亞Redwood市。
Founded in 1990 by Laura Colin and Henry Tom, Biostride is a researcher, developer and primary manufacturer of antibodies, antigen and enzyme conjugates for the IVD manufacturing industry worldwide. The company is particularly well known for its main product lines of Drugs of Abuse and Hormone testing components. Biostride is headquartered in Redwood City, California.
“我們很高興收購(gòu)了Biostride，其抗體、抗原產(chǎn)品作為關(guān)鍵原料被大量全球領(lǐng)先的試劑盒生產(chǎn)商用于藥物濫用檢測(cè)產(chǎn)品的生產(chǎn)。本次并購(gòu)會(huì)將Biostride的產(chǎn)品納入Medix Biochemica經(jīng)ISO13485認(rèn)證的生產(chǎn)標(biāo)準(zhǔn)中，這與Medix通過(guò)供應(yīng)鏈整合、成為IVD行業(yè)首選的關(guān)鍵原料供應(yīng)商的長(zhǎng)期戰(zhàn)略完全一致”，Medix Biochemica集團(tuán)首席執(zhí)行官Steve Ferguson如此說(shuō)。
“We are excited about the acquisition of Biostride, whose antibody and antigen products have been integrated as critical components into the Drug of Abuse tests of various world-leading test manufacturers. The acquisition will bring Biostride's products under Medix Biochemica's ISO 13485 certified manufacturing standard and is perfectly in line with Medix Biochemica's strategy to consolidate the IVD supply chain and become the #1 supplier of critical raw materials for IVD test manufacturers”, says Steve Ferguson, CEO of Medix Biochemica.
“加入Medix Biochemica對(duì)于Biostride來(lái)說(shuō)是順理成章的一步，我們相信Medix Biochemicar的大規(guī)模生產(chǎn)能力、基于北美、歐洲和中國(guó)的全球銷(xiāo)售網(wǎng)絡(luò)將使Biostride獲益良多”，Biostride總裁Todd Corneillie說(shuō)。
“Joining forces with Medix Biochemica is the natural next step in Biostride's journey. We are confident that Biostride will benefit from Medix Biochemica's large-scale manufacturing expertise and comprehensive global sales network, with local presence in North America, Europe and China”, says Todd Corneillie, President of Biostride.
如需更多信息，請(qǐng)聯(lián)系：
For more information:
Medix Biochemica中國(guó)商務(wù)團(tuán)隊(duì)
Commercial Team of Medix Biochemica China
Tel +86 21 6811 9180, 6811 9181, 6811 9105
Email: medixchina@medixbiochemica.com